kabutan

Welby Inc.(4438) Summary

4438
TSE Growth
Welby Inc.
313
JPY
+5
(+1.62%)
Apr 30, 11:30 am JST
1.95
USD
Apr 29, 10:30 pm EDT
Result
PTS
outside of trading hours
313.1
Apr 30, 11:29 am JST
Summary Chart Historical News Financial Result
PER
PBR
12.0
Yield
ー%
Margin Trading Ratio
Stock Price
Apr 30, 2026
Opening Apr 30, 9:00 am
308 JPY 1.92 USD
Previous Close Apr 28
308 JPY 1.93 USD
High Apr 30, 9:40 am
328 JPY 2.04 USD
Low Apr 30, 9:13 am
301 JPY 1.88 USD
Volume
36,900
Trading Value
0.01B JPY 0.07M USD
VWAP
315.34 JPY 1.97 USD
Minimum Trading Value
31,300 JPY 195 USD
Market Cap
2.64B JPY 0.02B USD
Number of Trades
134
Liquidity & Number of Trades
As of Apr 30, 2026
Liquidity
Mid
1-Year Average
196
1-Year High Mar 4, 2026
6,261
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 24, 2026 0 314,700
Apr 17, 2026 0 337,000
Apr 10, 2026 0 341,600
Apr 3, 2026 0 356,000
Mar 27, 2026 0 349,500
Company Profile
Welby Inc. provides personal health management platforms for lifestyle-related diseases and other conditions, primarily serving pharmaceutical companies, medical institutions, and healthcare-related organizations.
Sector
Information & Communication
Welby Inc. develops and operates PHR (Personal Health Record) platform services to support self-management for patients with lifestyle-related diseases and various other conditions. The company primarily works on commission from pharmaceutical companies to develop and manage platforms that promote proper use of new drugs and raise disease awareness upon market launch. Additionally, through its proprietary service "Welby MyKarte," the company supports self-management for patients with lifestyle-related diseases. These services facilitate information sharing between patients and healthcare professionals, contributing to treatment continuity and promoting self-health management. Revenue primarily consists of service development fees and usage fees from pharmaceutical companies, as well as charges to health insurance associations and corporations. With patient consent, accumulated data is also made available for sharing with healthcare professionals and for academic purposes.